Open Innovation case studies

Start Date 23/05/2017
Stockholm, Sweden

Putting open innovation into practice – case studies from Europe

An IMI symposium at the 6th Pharmaceutical Science World Congress (PSWC)

IMI is working to improve health by speeding up the development of the next generation of medicines, particularly in areas where there is an unmet medical or social need. It does this by facilitating open innovation among the key players involved in healthcare research, including universities, pharmaceutical companies, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators.

With this in mind, IMI teamed up with the International Pharmaceutical Federation (FIP) in the organisation of the 6th Pharmaceutical Science World Congress. The congress took place in Stockholm, Sweden, on 21 to 24 May 2017.

IMI's main focus at PSWC was ther organisation of a scientific symposium on 'Putting open innovation into practice – case studies from Europe' which took place on Tuesday 23 May. The symposium gathered approximately 60 people for a highly interactive debate with some of IMI's key stakeholders. It also provided a unique opportunity for IMI's flagship open innovation projects to discuss cross-project collaboration, challenges and opportunities.

Download the agenda

Download the presentations:

The eTOX project: pooling legacy data to advance safety sciences
Ferran Sanz, Spain, Pompeu Fabra University

Open PHACTS – creating a platform for drug discovery
Barend Mons, Leiden University Medical Center, the Netherlands

The European Lead Factory – making a pan-European compound collection & screening centre a reality
Dimitrios Tzalis, Taros Chemicals; IMI European Lead Factory project

The ENABLE project: an antibiotic discovery platform
Andes Karlen, University of Uppsala, Sweden

The ULTRA-DD project: delivering new tools and resources to speed up the development of truly innovative medicines
Michael Sundstrom, Karolinska Institute, Sweden

The symposium was chaired by Pierre Meulien, IMI's Executive Director. Pierre Meulien also provided an introductory presentation on open innovation and highlights from the Innovative Medicines Initiative.


About the 6th Pharmaceutical Science World Congress (PSWC)

This event provided a forum for an international network of pharmaceutical scientists to make an impact on the future of pharmaceutical sciences and global healthcare. PSWC 2017 provided scientists from all over the world with a place to meet and network with key leaders from the pharmaceutical industry, government agencies, regulatory bodies, academia and public-private partnerships. The Congress theme was: Future Medicines for One World - Systems approaches to drug discovery, development and clinical usage. For more information, please visit the website of the Pharmaceutical Science World Congress.